216 publications
Name | Date | Type | Actions |
---|---|---|---|
Annual results 2021 (slideshow) This document was prepared by Vetoquinol for the sole purpose of presenting the annual results for the year 2021 on March 24, 2022. |
24/03/2022 | Annual Report | |
[AUDIO] Présentation des résultats 2021 Présentation analystes & investisseurs - 24 mars 2022 |
24/03/2022 | Annual Report | |
Double-digit growth in 2021 Total Group Sales: €521 million (up 21.9% as reported) |
20/01/2022 | Public releases | |
Third quarter revenues: €132 million |
14/10/2021 | Public releases | |
2021 first half results 2021 Half year results |
29/07/2021 | Public releases | |
Availability of the 2020 universal registration document Vetoquinol informs that it has filed its 2020 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 28th, 2021. |
28/04/2021 | Public releases | |
Q1 2021 sales Q1 2021 sales : €128M (up 28% at constant exchange rates, up 24% as reported)
Q1 2021 essential sales : €72.6M (up 38% at constant exchange rates, up 36% as reported)
|
15/04/2021 | Public releases | |
[VIDEO ]Présentation des résultats 2020 - french Présentation analystes & investisseurs - 1er avril 2021 |
01/04/2021 | Annual Report | |
2020 annual results 2020 sales: €427.5m (up 8.0% as reported)
EBIT before depreciation of assets arising from acquisitions: €65.3m (up 33.5%)
Net income - Group share: €19.2m (4.5% of sales)
Cash flow: €92.2m
|
01/04/2021 | Public releases | |
Vetoquinol wins the Animal Pharm’s award for best European company 2020 February 8th, 2021 (Lure, France) - Vetoquinol announced today it has been awarded “Best European Company 2020” by Animal Pharm. |
08/02/2021 | Public releases |